Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid LeukemiaAreej El‐Jawahri, Jennifer S. Temel, D. Davis et al.|JAMA Oncology|2020Cited by 174
Haematopoietic cell transplantation with and without sorafenib maintenance for patients with <i> <scp>FLT</scp> 3 </i> ‐ <scp>ITD</scp> acute myeloid leukaemia in first complete remissionAndrew M. Brunner, Yi‐Bin Chen, Shuli Li et al.|British Journal of Haematology|2016Cited by 174
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settingsJacqueline S. Garcia, Robert J. Soiffer, Yael Flamand et al.|Blood|2022Cited by 51
Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemiaShai Shimony, Marlise R. Luskin, Yiwen Liu et al.|Blood Advances|2022Cited by 40
Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative studySabine Käyser, Mark J. Levis, Michael Krämer et al.|Haematologica|2021Cited by 34